Literature DB >> 18475497

Biological significance of soluble IL-2 receptor.

C Caruso1, G Candore, D Cigna, A T Colucci, M A Modica.   

Abstract

A NUMBER of receptors for growth factors and differentiation antigens have been found to be secreted or released by cells. Following mononuclear cell (MNC) activation and interleukin-2 receptor (IL-2R) expression, a soluble form of the Alpha;-chain of IL-2R (sIL-2R) is released. The sIL-2R has been shown to be present in the culture supernatants of activated MNCs as well as in normal sera and, in higher amounts, in sera from subjects affected by several diseases including neoplastic, infectious and autoimmune ones, and in sera from transplanted patients suffering allograft rejection. The blood sIL-2R levels depend on the number of producing cells and the number of molecules per cell, so that sIL-2R blood values may represent an index of the number and the functional state of producing cells, both normal and neoplastic. Thus, monitoring of the immune system, mostly T-cells and haematological malignancies might be targets for the measurement of sIL-2R. Since many conditions may influence sIL-2R production, little diagnostic use may result from these measurements. However, since blood sIL-2R levels may correlate with disease progression and/or response to therapy, their measurement may be a useful index of activity and extent of disease. The precise biological role of the soluble form of the IL-2R is still a matter of debate. However, we know that increased sIL-2R levels may be observed in association with several immunological abnormalities and that sIL-2R is able to bind IL-2. It is conceivable then that in these conditions the excess sIL-2R released in vivo by activated lymphoid cells or by neoplastic cells may somehow regulate IL-2-dependent processes. On the other hand, it cannot exclude that sIL-2R is a by-product without biological significance. Finally, it is puzzling that in many conditions in which an increase of blood sIL-2R values has been observed, MNCs display a decreased in vitro capacity to produce sIL-2R. These seemingly contrasting findings are discussed in the light of the data showing that sIL-2R production correlates with IL-2 production.

Entities:  

Year:  1993        PMID: 18475497      PMCID: PMC2365387          DOI: 10.1155/S0962935193000018

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  164 in total

1.  Plasma interleukin 2 receptor levels in renal allograft dysfunction.

Authors:  J L Forsythe; B K Shenton; N R Parrot; R M Taylor; G Proud
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

2.  Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis.

Authors:  S Cohen-Kaminsky; Y Jacques; C Aime; D Safar; E Morel; S Berrih-Aknin
Journal:  Clin Immunol Immunopathol       Date:  1992-02

3.  Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?

Authors:  R Dummer; G Posseckert; F Nestle; R Witzgall; M Burger; J C Becker; E Schäfer; J Wiede; W Sebald; G Burg
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

4.  Evolution of the levels of soluble interleukin-2 receptors during Plasmodium falciparum and P. vivax malaria.

Authors:  P Deloron; J P Lepers; P Coulanges
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

5.  Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

Authors:  D T Imagawa; M H Lee; S M Wolinsky; K Sano; F Morales; S Kwok; J J Sninsky; P G Nishanian; J Giorgi; J L Fahey
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

6.  Detection of soluble IL-2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM-CSF.

Authors:  H Zwierzina; M Herold; S Schöllenberger; D Geissler; F Schmalzl
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

7.  A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.

Authors:  T J Schroeder; T Helling; R M McKenna; D Rush; J R Jeffrey; B Brewer; L A Martin; D Traylor; R A Fisher; M R First
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

8.  Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

Authors:  I L Noronha; V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Elevated levels of soluble interleukin 2 receptor and tumor necrosis factor in nasopharyngeal carcinoma.

Authors:  M M Hsu; J Y Ko; Y L Chang
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-11

10.  Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

Authors:  J Brynskov; N Tvede; C B Andersen; M Vilien
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more
  34 in total

Review 1.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

2.  sTREM-1, sIL-2Rα, and IL-6, but not sCD163, might predict sepsis in polytrauma patients: a prospective cohort study.

Authors:  S Trancă; J T Oever; C Ciuce; M Netea; A Slavcovici; C Petrișor; N Hagău
Journal:  Eur J Trauma Emerg Surg       Date:  2016-05-12       Impact factor: 3.693

3.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

4.  The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.

Authors:  Xiang Yang Zhang; Dong Feng Zhou; Lian Yuan Cao; Gui Ying Wu
Journal:  Psychopharmacology (Berl)       Date:  2006-08-12       Impact factor: 4.530

5.  T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.

Authors:  Camilla A Lindqvist; Lisa H Christiansson; Bengt Simonsson; Gunilla Enblad; Ulla Olsson-Strömberg; Angelica S I Loskog
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

6.  Elevation of proinflammatory cytokines in patients with Aicardi-Goutières syndrome.

Authors:  Asako Takanohashi; Morgan Prust; Jichuan Wang; Heather Gordish-Dressman; Miriam Bloom; Gillian I Rice; Johanna L Schmidt; Yanick J Crow; Pierre Lebon; Taco W Kuijpers; Kanneboyina Nagaraju; Adeline Vanderver
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

7.  Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.

Authors:  M Maes; E Bosmans; H Y Meltzer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

8.  Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort.

Authors:  Nirzari Parikh; Will Dampier; Rui Feng; Shendra R Passic; Wen Zhong; Brian Frantz; Brandon Blakey; Benjamas Aiamkitsumrit; Vanessa Pirrone; Michael R Nonnemacher; Jeffrey M Jacobson; Brian Wigdahl
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

9.  Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.

Authors:  Xiang Yang Zhang; Lian Yuan Cao; Cai Song; Gui Ying Wu; Da Chun Chen; Ling Yan Qi; Fan Wang; Mei Hong Xiu; Song Chen; Yingyang Zhang; Lin Lu; Therese A Kosten; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2008-08-22       Impact factor: 4.530

Review 10.  Cytokine production pathway in the elderly.

Authors:  C Caruso; G Candore; D Cigna; G DiLorenzo; G Sireci; F Dieli; A Salerno
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.